Working… Menu
Trial record 1 of 1 for:    tactam
Previous Study | Return to List | Next Study

Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (TACTAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02291848
Recruitment Status : Recruiting
First Posted : November 17, 2014
Last Update Posted : April 1, 2019
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Premal Lulla, Baylor College of Medicine

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2019
Estimated Study Completion Date : April 2021